Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations.
Yang L, Shen K, Zhang M, Zhang W, Cai H, Lin L, Long X, Xing S, Tang Y, Xiong J, Wang J, Li D, Zhou J, Xiao M.
Yang L, et al. Among authors: zhang m, zhang w.
Front Oncol. 2019 Oct 24;9:1133. doi: 10.3389/fonc.2019.01133. eCollection 2019.
Front Oncol. 2019.
PMID: 31709191
Free PMC article.